RSVI-306

N/A

Report date: 2023/01/07 14:29:51
NME

Base Information

Drug NameRSVI-306
Drug Alias NameRSVI-306
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionMicroRNAs modulators
TargetsMicroRNAs
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesRosVivo Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesRosVivo Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A